Semaglutide GLP-1 works as a GLP-1 receptor agonist to regulate appetite and blood sugar, while tirzepatide combines GIP and GLP-1 receptor agonist actions for enhanced weight loss benefits
Like semaglutide, higher therapeutic doses have not been specifically studied in nursing mothers
Diarrhea from semaglutide typically occurs during the initial weeks of treatment or when doses are increased, and most cases diminish over time as the body adapts to the medication
Because of these risks, healthcare providers may recommend medical treatment when lifestyle changes alone have not produced sufficient results
GCGR/GIPR/GLP-1R agonist: OR: 0.21, 95%CI: 0.080.56, P = 1.98 10 3 ), and these findings were well replicated in an independent cohort
They do show that weight maintenance should be discussed early, before a patient reaches a goal weight or stops treatment abruptly